Neurocrine Biosciences (NBIX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurocrine Biosciences (NBIX)

NBIX 152.31

-1.6%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (545)	3/17/2000 9:49:00 AM
From: juneau_boy	Read Replies (3) of 1834

Any concern over market cap per employee in this market? The info below is summary of MSTL financials on this for a couple of companies including NBIX.... ........Some of the items for ISIP are 8 Qtr of cash, burn rate $7.8 mil/Q, risk is medium,5 yr earnings growth is 40%......also notable, ISIP is one of 4 that has a mkt cap per employee of less than $1 mil/employee, specifically $670,000 per employee vs one as high as $8 mil per employee (XOMA) and another at $5 mil per employee (NBIX)...........

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next